Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Luigi,Nocera

第一单位： Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy.

作者： Luigi,Nocera ^[1] ; Giuseppe,Fallara ^[1] ; Daniele,Raggi ^[2] ; Federico,Belladelli ^[1] ; Daniele,Robesti ^[1] ; Francesco,Montorsi ^[1] ; Pierre I,Karakiewicz ^[3] ; Bernard,Malavaud ^[4] ; Guillaume,Ploussard ^[5] ; Andrea,Necchi ^[2] ; Alberto,Martini ^[5]

作者单位： Division of Experimental Oncology/Unit of Urology, URI, Urological Research Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, Italy. ^[1] Department of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy. ^[2] Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada. ^[3] Department of Urology, Institut Universitaire du Cancer Toulouse - Oncopôle, Toulouse, France. ^[4] Department of Urology, Institut Universitaire du Cancer Toulouse - Oncopôle, Toulouse, France.;Department of Urology, La Croix du Sud Hospital, Toulouse, France. ^[5]

关键词 duration of response (DoR)individual patient data (IPD)metastatic renal cell carcinoma (mRCC)overall survival (OS)progression-free survival (PFS)reconstructed data

DOI 10.3389/fonc.2022.955894

PMID 36132135

发布时间 2022-09-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交